By John Vandermosten, CFA NASDAQ:RANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) started 2024 with topline outcomes from its Part I examine of RT-111, or ustekinumab, delivering the biologic with its ingestible robotic RaniPill (RP). Bioavailability of 84% relative to subcutaneous injection was achieved within the examine and the RT-111 was … Read more
By Brad Sorensen, CFA OTC:PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) introduced outcomes for the quarter ended January 31, 2024. The headline was beneath expectations and administration famous that the corporate was “challenged” within the quarter. Administration didn’t elaborate on what these challenges had been, however all geographical segments of the corporate’s … Read more
Karl Havens was an avid scenic photographer. The sundown picture used under was one in every of Haven’s most beloved sundown photographs he has captured on digicam. In 2019, Florida Sea Grant established a sustained student-focused analysis program on water high quality to commemorate the passing of this system’s former director, Dr. Karl Havens. The … Read more
